Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology

IMV Inc. is a Canada-based company. The Company has no business operations.

Add To Watchlist

GREY:IMVIF - Post Discussion

IMV Inc > Finalization of the Basket Clinical Study

View:

Post by Betteryear2 on Dec 21, 2021 7:49am

Finalization of the Basket Clinical Study

December 21, 2021 07:05 AM Eastern Standard Time

DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX™ platform to treat solid and hematologic cancers, today announced the finalization of the basket clinical study evaluating maveropepimut-S (MVP-S, previously known as DPX-Survivac) in combination with Merck’s KEYTRUDA® in patients with metastatic bladder and Micro-Satellite Instability High (MSI-H) solid tumors.

https://www.businesswire.com/news/home/20211221005127/en/

119